BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND NONO, Q15233, 4841, ENSG00000147140, NRB54, P54NRB, NMT55, P54
40 results:

  • 1. Role of RNA binding proteins of the
    Takeiwa T; Ikeda K; Horie K; Inoue S
    RNA Biol; 2024 Jan; 21(1):1-17. PubMed ID: 38551131
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. VHL suppresses autophagy and tumor growth through PHD1-dependent Beclin1 hydroxylation.
    Wang Z; Yan M; Ye L; Zhou Q; Duan Y; Jiang H; Wang L; Ouyang Y; Zhang H; Shen Y; Ji G; Chen X; Tian Q; Xiao L; Wu Q; Meng Y; Liu G; Ma L; Lei B; Lu Z; Xu D
    EMBO J; 2024 Mar; 43(6):931-955. PubMed ID: 38360997
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Non-POU Domain-Containing Octomer-Binding (nono) protein expression and stability promotes the tumorigenicity and activation of Akt/MAPK/β-catenin pathways in human breast cancer cells.
    Lone BA; Siraj F; Sharma I; Verma S; Karna SKL; Ahmad F; Nagar P; Sachidanandan C; Pokharel YR
    Cell Commun Signal; 2023 Jun; 21(1):157. PubMed ID: 37370134
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Significance of liquid-liquid phase separation (LLPS)-related genes in breast cancer: a multi-omics analysis.
    Xie J; Chen L; Wu D; Liu S; Pei S; Tang Q; Wang Y; Ou M; Zhu Z; Ruan S; Wang M; Shi J
    Aging (Albany NY); 2023 Jun; 15(12):5592-5610. PubMed ID: 37338518
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial.
    Harbeck N; Fasching PA; Wuerstlein R; Degenhardt T; Lüftner D; Kates RE; Schumacher J; Räth P; Hoffmann O; Lorenz R; Decker T; Reinisch M; Göhler T; Staib P; Gluz O; Schinköthe T; Schmidt M;
    Ann Oncol; 2023 Aug; 34(8):660-669. PubMed ID: 37201751
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Epidemiological and genetic evidence for the relationship between ABO blood group and human cancer.
    Cui H; Qu Y; Zhang L; Zhang W; Yan P; Yang C; Zhang M; Bai Y; Tang M; Wang Y; Chen L; Xiao C; Zou Y; Liu Y; Zhang L; Yang Y; Yao Y; Li J; Liu Z; Yang C; Jiang X; Zhang B
    Int J Cancer; 2023 Jul; 153(2):320-330. PubMed ID: 37074298
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Locus-Specific Enrichment Analysis of 5-Hydroxymethylcytosine Reveals Novel Genes Associated with breast Carcinogenesis.
    Ramasamy D; Rao AKDM; Balaiah M; Vittal Rangan A; Sundersingh S; Veluswami S; Thangarajan R; Mani S
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230901
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study.
    Dogan I; Ayhan M; Gurbuz M; Kucukarda A; Aydin E; Urun Y; Cicin I; Saip P
    Medicine (Baltimore); 2022 Sep; 101(35):e30147. PubMed ID: 36107512
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Validation of a patient-reported measure of social support provided by nurses in breast cancer care (SuPP-N): based on a cross-sectional patient survey in 83 German hospitals.
    Lubasch JS; Lee S; Wirtz MA; Pfaff H; Ansmann L
    BMJ Open; 2022 Apr; 12(4):e054015. PubMed ID: 35487734
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. LINC00963: A potential cancer diagnostic and therapeutic target.
    Xie Z; Zhong C; Shen J; Jia Y; Duan S
    Biomed Pharmacother; 2022 Jun; 150():113019. PubMed ID: 35462329
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. RNA-binding protein p54
    Shen M; Zhang R; Jia W; Zhu Z; Zhao L; Huang G; Liu J
    Cell Death Dis; 2022 Jan; 13(1):42. PubMed ID: 35013116
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The transcribed ultraconserved element uc.51 promotes the proliferation and metastasis of breast cancer by stabilizing nono.
    Shi X; Huang X; Chen R; Li Y; Xu Y; Zhang W; Zhu Q; Zha X; Wang J
    Clin Exp Metastasis; 2021 Dec; 38(6):551-571. PubMed ID: 34714466
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prioritising breast cancer theranostics: A current medical longing in oncology.
    Pandey PN; Saini N; Sapre N; Kulkarni DA; Tiwari DAK
    Cancer Treat Res Commun; 2021; 29():100465. PubMed ID: 34598060
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. SPHK1 contributes to cisplatin resistance in bladder cancer cells via the nono/STAT3 axis.
    Qin Z; Tong H; Li T; Cao H; Zhu J; Yin S; He W
    Int J Mol Med; 2021 Nov; 48(5):. PubMed ID: 34549307
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Risk stratification for prediction of locoregional recurrence in patients with pathologic T1-2N0 breast cancer after mastectomy.
    Wang J; Tang Y; Jing H; Sun G; Jin J; Liu Y; Song Y; Wang W; Fang H; Chen B; Qi S; Ren H; Li N; Tang Y; Lu N; Yang Y; Yu Z; Wang S; Li Y
    BMC Cancer; 2020 Nov; 20(1):1132. PubMed ID: 33228588
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Profiling of specific long non-coding RNA signatures identifies ST8SIA6-AS1 AS a novel target for breast cancer.
    Chen Z; Huang J; Feng Y; Li Z; Jiang Y
    J Gene Med; 2021 Feb; 23(2):e3286. PubMed ID: 33037712
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. RNA-binding protein nono contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC.
    Kim SJ; Ju JS; Kang MH; Eun JW; Kim YH; Raninga PV; Khanna KK; Győrffy B; Pack CG; Han HD; Lee HJ; Gong G; Shin Y; Mills GB; Eyun SI; Park YY
    Theranostics; 2020; 10(18):7974-7992. PubMed ID: 32724453
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Long non-coding RNA LINC-PINT attenuates paclitaxel resistance in triple-negative breast cancer cells via targeting the RNA-binding protein nono.
    Chen J; Zhu M; Zou L; Xia J; Huang J; Deng Q; Xu R
    Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):801-809. PubMed ID: 32632453
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. nono Is a Negative Regulator of
    Liang S; Takahashi H; Hirose T; Kuramitsu Y; Hatakeyama S; Yoshiyama H; Wang R; Hamada JI; Iizasa H
    Cancer Genomics Proteomics; 2020; 17(4):359-367. PubMed ID: 32576581
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Interfering MSN-nono complex-activated CREB signaling serves as a therapeutic strategy for triple-negative breast cancer.
    Qin Y; Chen W; Jiang G; Zhou L; Yang X; Li H; He X; Wang HL; Zhou YB; Huang S; Liu S
    Sci Adv; 2020 Feb; 6(8):eaaw9960. PubMed ID: 32128390
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.